Immunome, Inc.
Immunome, Inc. (IMNM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
imnm · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 13 Wall Street analysts in the past 3 months
Buy
13 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$40.00
Consensus
$36.33
+95.8% upside
Low
$32.00
Median: $36.5 · Last Close: $18.56
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$36.33
95.8% upside
High Target
$40
115.6%
Low Target
$32
72.5%
Current Price
$18.56
as of today
Based on analyst price targets, the IMNM stock price prediction for the next 12 months ranges from $32 to $40. The consensus IMNM price forecast of $36.33 implies 95.8% upside from the current price of $18.56.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $17.63 | ↓ 5.00% |
1-day model range: $17.51–$17.75. Peak: $17.75 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $19 | +3.9% |
| 2028 | $20 | +6.1% |
| 2029 | $20 | +7.4% |
| 2030 | $20 | +8.1% |
| 2031 | — | +8.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMNM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-15 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-03-04 | Craig-Hallum | Maintains | Buy→Buy |
| 2026-01-15 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-16 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-12-16 | Lake Street | Maintains | Buy→Buy |
| 2025-12-16 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-17 | Stephens & Co. | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Immunome, Inc. (IMNM) stock. Of the recent 25 rating actions, 0 were upgrades and 0 were downgrades. 13 analysts currently cover IMNM.
Analyst Recommendation Trends
IMNM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 98.9% YoY
Revenue Next Year
$62M
↑ 2355.8% YoY
EPS This Year
$-2.14
EPS Next Year
$-2.14
↓ 0.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMNM EPS of $-2.14 for the current fiscal year, based on estimates from 10 analysts. The IMNM revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IMNM stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IMNM price target is $36.33 (+95.8% upside), with an analyst consensus of Buy.
The IMNM short-term stock prediction for tomorrow is $17.63 (-5.00%). The IMNM stock price prediction for 2027 estimates an average of $19. The IMNM stock prediction for 2030 projects a range of $19–$22.
Immunome, Inc. trades on NASDAQ under the ticker IMNM. The IMNM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
IMNM forecast · 8 questionsAccording to 13 Wall Street analysts, the average 12-month IMNM price target is $36.33, with a high forecast of $40.00 and a low of $32.00. The median price target is shown in the chart above when available. This implies +95.8% potential upside from the current price of $18.56.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.